Q1 Earnings Estimate for Revvity Issued By Leerink Partnrs

Revvity, Inc. (NYSE:RVTY) – Research analysts at Leerink Partnrs decreased their Q1 2025 earnings per share (EPS) estimates for Revvity in a research report issued on Friday, November 22nd. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings per share of $1.09 for the quarter, down from their previous forecast of $1.14. The consensus estimate for Revvity’s current full-year earnings is $4.85 per share. Leerink Partnrs also issued estimates for Revvity’s Q4 2025 earnings at $1.47 EPS.

RVTY has been the subject of a number of other reports. Citigroup increased their price target on shares of Revvity from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. JPMorgan Chase & Co. increased their target price on Revvity from $105.00 to $120.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 30th. Raymond James lifted their price target on Revvity from $144.00 to $146.00 and gave the company an “outperform” rating in a research report on Tuesday, November 5th. Barclays decreased their price objective on Revvity from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Monday. Finally, Leerink Partners boosted their target price on shares of Revvity from $130.00 to $135.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Seven investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Revvity currently has a consensus rating of “Moderate Buy” and a consensus target price of $131.73.

Revvity Stock Up 0.4 %

Shares of NYSE RVTY opened at $115.14 on Monday. The firm has a fifty day simple moving average of $120.22 and a two-hundred day simple moving average of $115.89. Revvity has a 12 month low of $86.30 and a 12 month high of $129.50. The company has a current ratio of 3.56, a quick ratio of 2.97 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $14.01 billion, a PE ratio of 55.62, a price-to-earnings-growth ratio of 2.80 and a beta of 1.05.

Revvity (NYSE:RVTY) last posted its earnings results on Monday, November 4th. The company reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.15. Revvity had a return on equity of 7.42% and a net margin of 9.34%. The firm had revenue of $684.10 million for the quarter, compared to analysts’ expectations of $679.66 million. During the same period in the previous year, the firm earned $1.18 earnings per share. The business’s revenue was up 2.1% compared to the same quarter last year.

Institutional Investors Weigh In On Revvity

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Rothschild Investment LLC purchased a new position in shares of Revvity in the second quarter worth approximately $25,000. Gladius Capital Management LP bought a new stake in shares of Revvity during the 3rd quarter valued at $32,000. EverSource Wealth Advisors LLC increased its stake in shares of Revvity by 74.2% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 392 shares of the company’s stock worth $41,000 after purchasing an additional 167 shares in the last quarter. Family Firm Inc. purchased a new position in Revvity during the second quarter valued at $43,000. Finally, Fairfield Financial Advisors LTD purchased a new position in Revvity during the second quarter valued at $43,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Insider Activity at Revvity

In other news, insider Tajinder S. Vohra sold 2,154 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $121.73, for a total transaction of $262,206.42. Following the sale, the insider now owns 19,652 shares of the company’s stock, valued at $2,392,237.96. This trade represents a 9.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.60% of the stock is currently owned by insiders.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 7th. Investors of record on Friday, January 17th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, January 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.24%. Revvity’s payout ratio is currently 13.53%.

Revvity declared that its board has authorized a share buyback plan on Monday, November 4th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.5% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s leadership believes its shares are undervalued.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.